bioRxivNeurosciencePreprint
Rapid generation of ventral A9-like dopaminergic neurons from patterned iPSCs
Kriti ChaplotiD, Lin ZhangiD, Julia Wessman, Miguel RiveraiD, Zhihui WangiD, Fei WangiD, Xin DuaniD, Pamela M. EnglandiD, Iain C. ClarkiD, Erik M. UllianiD
Abstract
In vitro modelling of highly vulnerable nigral dopaminergic (DA) neuronal subtypes in Parkinsons disease (PD), is necessary for studying disease mechanisms. Here, we optimized a new approach by expressing the pioneer neurogenic transcription factor, Achaete-scute-like 1 (Ascl1), implicated in determining dopaminergic fate. Sequential small-molecule patterning of iPSCs into early floor plate mesencephalic progenitors, followed by inducible Ascl1 expression, rapidly differentiates midbrain DA neurons. Immunocytochemistry and transcriptomic analysis of these patterned Ascl1-driven DA neurons (PA-DANs) confirmed midbrain-lineage specificity. Importantly, we found an enrichment of DA subpopulations that corresponded to the adult human ventral SOX6-positive A9 DA subtypes vulnerable in PD. Furthermore, we combined these ventral A9-like PA-DANs with human iPSC-derived midbrain astrocytes and microglia in defined ratios to generate mature 3D A9-like assembled organoids that display characteristic spontaneous neuronal activity and electrical propagation along the axon. Our method efficiently generates a mature and functional A9-like DA neuronal platform to study PD. HighlightsO_LISequential midbrain patterning and Ascl1 expression accelerates DA differentiation C_LIO_LIPA-DANs resemble human adult ventral A9-like DA subtypes vulnerable in PD C_LIO_LI3D assembled organoids show mature identity of PA-DANs, iAstrocytes and iMicroglia C_LIO_LIPA-DANs matured in 3D organoids show neuronal network activity within weeks C_LI eTOC blurbIn this study, Ullian and colleagues have developed a rapid method to differentiate dopaminergic neurons, using small molecules to generate early floor plate mesencephalic progenitors from human iPSCs and sequentially expressing a pioneer transcription factor, Ascl1, that accelerates uniform dopaminergic neurogenesis. Patterned Ascl1-driven dopaminergic neurons (PA-DANs) in 2D and 3D assembled organoids serve as a platform to study Parkinsons disease O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=182 SRC="FIGDIR/small/685897v1_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@1d83eb3org.highwire.dtl.DTLVardef@1fc7fa5org.highwire.dtl.DTLVardef@2033e3org.highwire.dtl.DTLVardef@2e8fa3_HPS_FORMAT_FIGEXP M_FIG C_FIG
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Decoding subtype development and function in human pluripotent stem cell-derived midbrain dopaminergic neurons
Donghe Yang, Sejoon Choi, … Lorenz Studer·bioRxiv·Sep 24, 2026
- Transcription factor-mediated generation of dopaminergic neurons from human iPSCs: a comparison of methods
Kirstin O. McDonald, Nikita M. A. Lyons, … Indranil Basak·CellsPeer-reviewed·Jun 11, 2024
- Multi-omics reveal critical differentiation target for Parkinsons' Disease-vulnerable midbrain dopaminergic neurons
Roberto García‐Swinburn, Guochang Lyu, … Ernest Arenas·bioRxiv·Jun 18, 2025
- Single cell transcriptional and functional analysis of human dopamine neurons in 3D fetal ventral midbrain organoid like cultures
Marcella Birtele, Yogita Sharma, … Malin Parmar·bioRxiv·Oct 1, 2020
- Induction of Dopaminergic Neurons for Neuronal Subtype-Specific Modeling of Psychiatric Disease Risk
Samuel K. Powell, Callan P. O’Shea, … Kristen Brennand·Molecular PsychiatryPeer-reviewed·Sep 7, 2021
- A molecular census of midbrain dopaminergic neurons in Parkinson's disease
Tushar Kamath, Abdulraouf Abdulraouf, … Evan Z. Macosko·bioRxiv·Jun 16, 2021